• 4 October 2011

    JenaValve transapical TAVI system receives CE mark approval

    JenaValve Technology, a Germany-based medical device company, has received CE mark approval for its second-generation transapical transcatheter aortic valve implantation (TAVI) system, designed to treat severe aortic valve stenosis in...

  • 4 October 2011

    Getinge to buy Atrium Medical

    Getinge, a global medical technology company with operations in the areas of surgery, intensive care, infection control, care ergonomics and wound care, has signed a binding agreement to acquire all...

  • 3 October 2011

    Atrium Advanta stent shows superiority against PAD

    Atrium Medical's covered versus balloon expandable stent trial (COBEST) demonstrated positive results of Atrium's proprietary balloon expandable covered stent technology over traditional bare metal stents (BMS) for the treatment of...

  • 2 October 2011

    Calypso receives IDE approval for lung cancer study

    The US Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval for Calypso Medical's clinical study evaluating Calypso systems' viability to precisely track lung cancer tumours during radiation...

  • 2 October 2011

    FDA clears KCHC pediatric face mask

    Kimberly-Clark Health Care (KCHC) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its pediatric face mask.

  • 2 October 2011

    NuVasive to purchase Impulse Monitoring

    NuVasive has accomplished a definitive agreement to acquire Impulse Monitoring, an intra-operative monitoring (IOM) provider in the United States for $80m, comprised of $40m in cash and $40m in stock.

Go Top